This inventor holds 3 USPTO granted patents. Top assignees: American Cyanamid Company, Other. Active years: 1993-1996.
Location History:
- Arlington, TX (US) (1993)
- New City, NY (US) (1996)
Company Filing History:
2 out of 3,580 
1 out of 834,350 Years Active: 1993-1996
Title: Romulus K Brazzell: Innovator in Glaucoma Treatment
Introduction
Romulus K Brazzell is a notable inventor based in New City, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma and ocular hypertension. With a total of 3 patents to his name, Brazzell's work has had a meaningful impact on medical treatments.
Latest Patents
Brazzell's latest patents focus on innovative methods for treating glaucoma. One of his inventions involves the treatment of glaucoma and ocular hypertension using a compound formula that allows for effective topical or systemic administration. Another patent details the use of beta-3-adrenergic agonists, specifically substituted 5-2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles, which are beneficial in managing elevated intraocular pressure and glaucoma.
Career Highlights
Throughout his career, Brazzell has worked with prominent organizations, including the American Cyanamid Company. His expertise in the field has led to advancements in therapeutic approaches for eye health.
Collaborations
Brazzell has collaborated with notable individuals in his field, including Bernard Dubnick and Gerald Hecht. These partnerships have contributed to the development and refinement of his innovative treatments.
Conclusion
Romulus K Brazzell's contributions to glaucoma treatment exemplify the importance of innovation in medical science. His patents and collaborations highlight his commitment to improving patient care and advancing ophthalmic therapies.